1. 1. Bernal W, Smith HM, Williams R. A community prevalence study of antibodies to hepatitis A and E in inner-city London. J Med Virol 1996;49(3):230-4, DOI: 10.1002/(sici)1096-9071(199607)49:3
2. Drexler JF, Corman VM, Lukashev AN, van den Brand JMA, Gmyl AP, Brünink S, et al. Evolutionary origins of hepatitis A virus in small mammals. PNAS 2015;112(49):15190-5, DOI: 10.1073/pnas.1516992112.
3. Xing L, Li T-C, Mayazaki N, Simon MN, Wall JS, Moore M, et al. Structure of Hepatitis E Virion-sized Particle Reveals an RNA-dependent Viral Assembly Pathway*. J Biol Chem 2010;285(43):33175-83, DOI: 10.1074/jbc.m110.106336.
4. Purcell RH, Emerson SU. Hepatitis E: An emerging awareness of an old disease. J Hepatol 2008;48(3):494-503, DOI: 10.1016/j.jhep.2007.12.008.
5. Lemon SM. Type A Viral Hepatitis. N Engl J Med 1985;313(17):1059-67, DOI: 10.1056/nejm198510243131706.
6. Gallian P, Piquet Y, Assal A, Djoudi R, Chiaroni J, Izopet J, et al. Virus de l’hépatite E, implications en transfusion sanguine. Transfus Clin Biol 2014;21(4-5):173-7, DOI: 10.1016/j.tracli.2014.07.007.
7. Lee EJ, Kwon SY, Seo TH, Yun HS, Cho HS, Kim BK, et al. Clinical features of acute hepatitis A in recent two years. Korean J Gastroenterol 2008;52(5):298-303,
8. Risalde MA, Rivero-Juárez A, Romero-Palomo F, Frías M, López-López P, Cano-Terriza D, et al. Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar. PLOS ONE 2017;12(11):e0186858, DOI: 10.1371/journal.pone.0186858.
9. Belei O, Ancusa O, Mara A, Olariu L, Amaricai E, Folescu R, et al. Current Paradigm of Hepatitis E Virus Among Pediatric and Adult Patients. 2021;9(1032), DOI: 10.3389/fped.2021.721918.
10. Webb GW, Kelly S, Dalton HR. Hepatitis A and Hepatitis E: Clinical and Epidemiological Features, Diagnosis, Treatment, and Prevention. Clin Microbiol Newsl 2020;42(21):171-9, DOI: 10.1016/j.clinmicnews.2020.10.001.
11. Haeri Mazanderani A, Motaze NV, McCarthy K, Suchard M, du Plessis NM. Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005–2015. PLOS ONE 2019;14(6):e0216033, DOI: 10.1371/journal.pone.0216033.
12. Kamar N, Bendall R, Legrand-Abravanel F, Xia N-S, Ijaz S, Izopet J, et al. Hepatitis E. The Lancet 2012;379(9835):2477-88, DOI: 10.1016/s0140-6736(11)61849-7.
13. Ndumbi P, Freidl GS, Williams CJ, Mårdh O, Varela C, Avellón A, et al. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European :union: and European Economic Area, June 2016 to May 2017. Eurosurveillance 2018;23(33), DOI: 10.2807/1560-7917.es.2018.23.33.1700641.
14. Khuroo M, Khuroo M, Khuroo N. Transmission of Hepatitis E Virus in Developing Countries. Viruses 2016;8(9):253, DOI: 10.3390/v8090253.
15. Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Najafi-Tireh Shabankareh A, Sharifi Olyaie R, et al. Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran. Hepat Mon
2016;16(1), DOI: 10.5812/hepatmon.32215.
16. Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, et al. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect 2016;144(2):291-6, DOI: 10.1017/s0950268815001302.
17. Izadi M, Esfahani AA, Hassannia H, Jafari NJ, Najarkolaei FR, Rezaee-Zavareh MS. Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterol Hepatol Bed Bench 2016;9(2):100,
18. Behzadifar M, Lankarani KB, Abdi S, Taheri Mirghaed M, Beyranvand G, Keshavarzi A, et al. Seroprevalence of Hepatitis E Virus in Iran: A Systematic Review and Meta-analysis. Middle East J Dig Dis 2016;8(3):189-200, DOI: 10.15171/mejdd.2016.31.
19. Alavian SM. Occult hepatitis B virus infection in hemodialysis patients. Hepat Mon 2012;12(4):242-3, DOI: 10.5812/hepatmon.869.
20. Ghasemian R, Babamahmoodi F, Ahangarkani F. Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report. Hepat Mon 2016;16(6), DOI: 10.5812/hepatmon.38138.
21. Alian S, Ajami A, Ghasemian R, Yadegarinia D. 754 Age-specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran. East Mediterr Health J 2011;17(10):754-8, DOI: 10.26719/2011.17.10.754.
22. Saffar MJ, Farhadi R, Ajami A, Khalilian AR, Babamahmodi F, Saffar H. Seroepidemiology of hepatitis E virus infection in 2-25-year-olds in Sari district, Islamic Republic of Iran. East Mediterr Health J 2009;15(1):136-42, DOI: 10.26719/2009.15.1.136.
23. Tahamtan A, Moradi A, Ghaemi A, Kelishadi M, Ghafari H, Hashemi P, et al. Seroepidemiology of Hepatitis E Virus in hemodialysis patients in Gorgan-Iran. Med Lab J 2013;7(2):13-7,
24. Merat SH, Rezvan H, Nouraei M, Abou Alghasemi H, Jamali R, Amini Kafiabad S, et al. Seroprevalence and risk factors of hepatitis a virus infection in iran: a population based study. Arch Iran Med 2010;13(2):99-104,
25. Mohebbi SR, Rostami Nejad M, Tahaei SME, Pourhoseingholi MA, Habibi M, Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg 2012;106(9):528-31, DOI: 10.1016/j.trstmh.2012.05.013.
26. Elikaei A, Sharifi Z, Shooshtari MM, Hosseini M, Maroufi Y. Prevalence of HAV among healthy blood donors referring to Tehran transfusion center. Iran J Public Health 2008;37(4):126-30,
27. Ramezani H, Bozorgi S, Nooranipour M, Mostajeri A, Kargar-Fard H, Molaverdikhani S, et al. Prevalence and risk factors of hepatitis A among blood donors in Qazvin, central Iran. Singapore Med J 2011;52(2):107-12,
28. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SAR. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, Southwest Iran. Int J Infect Dis 2008;12(4):387-90, DOI: 10.1016/j.ijid.2007.09.015.
29. Aminiafshar S, Alimagham M, Gachkar L, Yousefi F, Attarchi Z. Anti hepatitis E virus seropositivity in a group of blood donors. Iran J Public Health 2004;33(4):53-6,
30. Taremi M, Gachkar L, MahmoudArabi S, Kheradpezhouh M, Khoshbaten M. Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran. East Mediterr Health J 2007;13:98-102,
31. Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi S, et al. Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol 2013;5(2):172,
32. Johargy AK, Mahomed MF, Khan MM, Kabrah S. Anti hepatitis E virus seropositivity in a group of male blood donors in Makkah, Saudi Arabia. J Pak Med Assoc 2013;63(2):185-9,
33. Petrović T, Lupulović D, Jiménez de Oya N, Vojvodić S, Blázquez A-B, Escribano-Romero E, et al. Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors. J Infect Dev Ctries 2014;8(10):1322-7, DOI: 10.3855/jidc.4369.
34. Koroglu M, Jacobsen KH, Demiray T, Ozbek A, Erkorkmaz U, Altindis M. Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa. J Infect Public Health 2017;10(5):513-7, DOI: 10.1016/j.jiph.2016.09.020.
35. Cardenas A, Smit E, Bethel JW, Houseman EA, Kile ML. Arsenic exposure and the seroprevalence of total hepatitis A antibodies in the US population: NHANES, 2003–2012. Epidemiol Infect 2016;144(8):1641-51, DOI: 10.1017/s0950268815003088.
36. Carrillo-Santisteve P, Tavoschi L, Severi E, Bonfigli S, Edelstein M, Byström E, et al. Seroprevalence and susceptibility to hepatitis A in the European :union: and European Economic Area: a systematic review. Lancet Infect Dis 2017;17(10):e306-e19, DOI: 10.1016/s1473-3099(17)30392-4.
37. Khojah A, Felimban R, Kabrah S, Alqasmi M. Prevalence of Kell Blood Group System in Blood Donors of Makkah City, Saudi Arabia. Clin Lab 2021;67(06/2021), DOI: 10.7754/clin.lab.2020.200946.
38. Taghavi SA, Asl MKH, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon 2011;11(4):285.
2. Evolutionary origins of hepatitis A virus in small mammals
3. Structure of Hepatitis E Virion-sized Particle Reveals an RNA-dependent Viral Assembly Pathway*
4. Hepatitis E: An emerging awareness of an old disease